Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 29, 16 January 2024
* Author to whom correspondence should be addressed.
OVERMAN M J, LONARDI S, WONG K Y M, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer [J]. J Clin Oncol, 2018, 36(8): 773-779.
Kidney cancer, diagnosis methods, biotechnology.
1. Zhouyi Y, Mengyuan W, Weicheng W, et al 2022 Electronic Journal of Comprehensive Tumor Therapy 8 2 54-63
2. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
3. Gossage, L., Eisen, T. & Maher, E. Nat Rev Cancer 15 55–64
4. Metabolic syndrome; Renal cancer; Risk; Invasiveness; Prognostic
5. Xinyi Z, Junhua Z, Wei Z 2023 Recent advances in diagnosis and treatment of renal cell carcinoma Chinese Journal of Oncology Prevention and Treatment 15 4 375-382
6. Kimberly L. Shampain, Prasad R. Shankar, Jonathan P. Troost, et al 2022 Davenport Radiology 2022 302 2 357-366
7. Bukowski K, Kciuk M, Kontek R. 2020 International journal of molecular sciences 21 9 3233
8. Catalano A, Iacopetta D, Ceramella J, et al 2022 Molecules 27 3 616
9. Huiyun Y, Yufei J, YutingT, et al 2021 Research on Cancer Prevention and Treatment 48 06 642-646
10. Ling S, Zaccardi F, Issa E, et al 2023 Diabetologia 66 4 657-673
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).